Aberrant expression of ALK and EZH2 in Merkel cell carcinoma

Show full item record



Permalink

http://hdl.handle.net/10138/187959

Citation

Veija , T , Koljonen , V , Bohling , T , Kero , M , Knuutila , S & Sarhadi , V K 2017 , ' Aberrant expression of ALK and EZH2 in Merkel cell carcinoma ' , BMC Cancer , vol. 17 , 236 . https://doi.org/10.1186/s12885-017-3233-5

Title: Aberrant expression of ALK and EZH2 in Merkel cell carcinoma
Author: Veija, T.; Koljonen, V.; Bohling, T.; Kero, M.; Knuutila, S.; Sarhadi, Virinder Kaur
Contributor: University of Helsinki, Medicum
University of Helsinki, Clinicum
University of Helsinki, HUSLAB
University of Helsinki, HUSLAB
University of Helsinki, Medicum
University of Helsinki, Medicum
Date: 2017-03-31
Language: eng
Number of pages: 9
Belongs to series: BMC Cancer
ISSN: 1471-2407
URI: http://hdl.handle.net/10138/187959
Abstract: BACKGROUND: Distinct characteristic features categorize Merkel cell carcinoma (MCC) into two subgroups according to the Merkel cell polyomavirus infection. Many mutational studies on MCC have been carried out in recent years without identifying a prominent driver mutation. However, there is paucity reporting the expression of cancer genes at the RNA level in MCC tumors. In this study, we studied the RNA expression profiles of 26 MCC tumors, with a goal to identify prospective molecular targets that could improve the treatment strategies of MCC. METHODS: RNA expression of 50 cancer-related genes in 26 MCC tumors was analyzed by targeted amplicon based next-generation sequencing using the Ion Torrent technology and the expression compared with that of normal, non-cancerous skin samples. Sequencing data were processed using Torrent Suite Software. Expression profiles of MCV-negative and MCV-positive tumors were compared. Fluorescence in situ hybridization was performed to study ALK rearrangements and immunohistochemistry to study ALK expression in tumor tissue. RESULTS: ALK, CDKN2A, EZH2 and ERBB4 were overexpressed, and EGFR, ERBB2, PDGFRA and FGFR1 were underexpressed in MCC tumors compared to normal skin. In the MCV-negative tumors, MET, NOTCH1, FGFR3, and SMO were overexpressed and JAK3 and NPM1 were under-expressed compared to the MCV-positive tumors. CONCLUSIONS: High expression of ALK, CDKN2A and EZH2 was recorded in MCC tumors. No ALK fusion was seen by FISH analysis. Overexpression of EZH2 suggests its potential as a drug target in MCC.
Subject: ALK
EZH2
Merkel cell carcinoma
Next-generation sequencing
RNA
3122 Cancers
3111 Biomedicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
art_3A10.1186_2Fs12885_017_3233_5.pdf 1.288Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record